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ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) strains are leading causes of hospital-acquired infections in the
UnitedStates,andclonalcluster5(CC5)isthepredominantlineageresponsiblefortheseinfections.Since2002,therehavebeen
12 cases of vancomycin-resistant S. aureus (VRSA) infection in the United States—all CC5 strains. To understand this genetic
backgroundandwhatdistinguishesitfromotherlineages,wegeneratedandanalyzedhigh-qualitydraftgenomesequencesfor
allavailableVRSAstrains.SequencecomparisonsshowunambiguouslythateachstrainindependentlyacquiredTn1546and
thatallVRSAstrainslastsharedacommonancestorover50yearsago,wellbeforetheoccurrenceofvancomycinresistancein
thisspecies.IncontrasttoexistinghypothesesonwhatpredisposesthislineagetoacquireTn1546,thebarrierposedbyrestric-
tionsystemsappearstobeintactinmostVRSAstrains.However,VRSA(andotherCC5)strainswerefoundtopossessaconstel-
lationoftraitsthatappearstobeoptimizedforproliferationinpreciselythetypesofpolymicrobicinfectionwheretransfer
couldoccur.Theylackabacteriocinoperonthatwouldbepredictedtolimittheoccurrenceofnon-CC5strainsinmixedinfec-
tionandharboraclusterofuniquesuperantigensandlipoproteinstoconfoundhostimmunity.Aframeshiftin dprA,whichin
othermicrobesinﬂuencesuptakeofforeignDNA,mayalsomakethislineageconducivetoforeignDNAacquisition.
IMPORTANCE Invasive methicillin-resistant Staphylococcus aureus (MRSA) infection now ranks among the leading causes of
deathintheUnitedStates.Vancomycinisakeylast-linebactericidaldrugfortreatingtheseinfections.However,since2002,van-
comycin resistance has entered this species. Of the now 12 cases of vancomycin-resistant S. aureus (VRSA), each was believed to
representanewacquisitionofthevancomycin-resistanttransposonTn1546fromenterococcaldonors.Allacquisitionsof
Tn1546sofarhaveoccurredinMRSAstrainsoftheclonalcluster5geneticbackground,themostcommonhospitallineagecaus-
inghospital-acquiredMRSAinfection.Tounderstandthenatureofthesestrains,wedeterminedandexaminedthenucleotide
sequencesofthegenomesofallavailableVRSA.Genomecomparisonidentiﬁedcandidatefeaturesthatpositionstrainsofthis
lineagewellforacquiringresistancetoantibioticsinmixedinfection.
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T
welve cases of vancomycin-resistant Staphylococcus aureus
(VRSA) infection have been reported in the United States
since 2002 (1). Each is believed to represent a de novo acquisition
of Tn1546 from enterococci in a clonal cluster 5 (CC5)
methicillin-resistant S. aureus (MRSA) (2). CC5 includes strains
of pulsed-ﬁeld gel electrophoresis (PFGE) types USA100 and
USA800 and also contains the UK-EMRSA-3 strain, the New
York-Japan clone, the Pediatric clone, the Rhine-Hesse epidemic
strain, and the Canadian MRSA-2 strain (3).
CC5strainsareleadingcausesofhospital-associatedS.aureusin-
fection in the United States (4). They predominate in burn units,
among blood isolates, and in intensive care nurseries (5–8) and rank
among the leading causes of S. aureus infection globally (9, 10). CC5
strains were identiﬁed among early methicillin-resistant isolates in
the 1960s (11) and were shown to have acquired staphylococcal cas-
sette chromosome mec (SCCmec) at least 23 separate times (10).
MRSA strains with reduced susceptibility to glycopeptide antibiotics
(vancomycin- or glycopeptide-intermediate S. aureus [VISA or
GISA,respectively])(12)arisebyspontaneouspointmutationsincell
wall synthesis genes (13) and are almost always CC5 (14).
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fromacquisitionofTn1546fromenterococciduringthecourseof
infection (15). Tn1546 confers the VanA phenotype. Curiously,
mostoftheTn1546werefromanEnterococcusfaecalisdonor(15–
17), as opposed to the more common vancomycin-resistant En-
terococcus faecium (18). Nine VRSA strains arose in southeast
Michigan, where Tn1546 transfer was mediated by a broad-host-
range conjugative Inc18 plasmid (15–17, 19).
The repeated acquisition of vancomycin resistance by CC5,
along with its involvement in the early acquisition of methicillin
resistance and resistance to other antibiotics (11), suggests that it
isgeneticallyorbiologicallypredisposedtohorizontalacquisition
of resistance and possibly other genes. Such transfer requires that
donors and recipients coexist intimately in a mixed community,
and that they achieve a population size that allows them to over-
come inefﬁciencies and obstacles to transfer, genetic element es-
tablishment, and resistance expression. Thus, it was of interest to
examine VRSA genomes for barriers to entry of foreign DNA as
wellasfortraitsthatcouldfostertheirexistenceinmixedinfection
with potential resistance donors. We therefore generated high-
quality draft genome sequences of the available 12 CC5 VRSA
isolates from the ﬁrst 11 VRSA cases in the United States and
examinedthemfortraitsthatmayhavepredisposedthislineageto
vancomycin resistance acquisition.
RESULTS
North American CC5 phylogeny. We determined a core gene
sequence-based phylogeny for VRSA, based on 1,822 single-copy
orthologs present in all genomes (Fig. 1). Strains do not cluster
based on site or time of isolation (Fig. 1), supporting their inde-
pendent development into VRSA. Strain VRS3a, isolated in New
York in 2004 (the only PFGE type USA800 strain) is the most
divergent. MRSA strain JH1 and its GISA derivative JH9, which
arose during antimicrobial therapy (13, 20), are nested deeply
withintheVRSA.ThisphylogenyshowsthatallVRSAstrainsstem
from a monophyletic source, supporting the hypothesis that they
harboratraitortraitsthatpredisposethemforvancomycinresis-
tance acquisition or expression.
Tn1546 haplotype network. To determine whether Tn1546
evolvedalongapathdifferentfromtherestofthechromosome(as
would be expected if Tn1546 were repeatedly, independently ac-
quired as opposed to having been acquired once and then passed
along vertically with the rest of the chromosome), Tn1546 se-
quenceswerecompared,andtheirrelationshipstoeachotherand
to possible donor elements were calculated (17, 19) (Fig. 2).
Tn1546 sequences segregate regionally, as opposed to temporally
(e.g., transposons from strains isolated in New York, Pennsylva-
nia, and Delaware [strains VRS2, VRS3a, and VRS11a or VRS11b
{VRS11a/b}])sharefeatureswitheachotherthatarenotsharedby
strains from Michigan (e.g., strains VRS1 and VRS4), consistent
with an independent acquisition model (Fig. 2). All Tn1546 se-
quencesfromMichiganVRSAstrainsformatightclusterwithfew
single-nucleotide polymorphisms (SNPs). Tn1546 in E. faecalis
VRE5, coisolated with VRS5 (17), possesses a 491-bp duplication
missing in VRS5, suggesting that either VRE5 is not the Tn1546
donororthattheduplicationoccurredinthedonoraftertransfer.
FIG 1 Phylogeny based on single-copy core orthologs (n  1,822). Phylogeny showing the relationship of VRSA genomes to other completely sequenced
S.aureusgenomes.Thedate(month/day/year)andgeographiclocationoftheVRSAstrainandmultilocussequencetype(MLST)areindicatedintheexpanded
section.MI,Michigan;PA,Pennsylvania;NY,NewYork;DE,Delaware;MD,Maryland;JP,Japan;NIR,NorthernIreland.Bootstrapvaluesareindicatedateach
node. Scale bars correspond to number of changes per site.
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in VRS4, as well as to transposons in putative enterococcal donor
strains VRE6 and VRS6. Tn1546 from the plasmid in putative
donor VRE9 differs from that in VRS9 by a single SNP (Fig. 2).
Tn1546 of strains VRS2 and VRS3a were reported to possess
insertions of IS1251 between vanS and vanH, as well as copies of
IS1216withinorf1thatareinvertedinthetwostrains(21,22).The
Tn1546portionsofthesecompositeelementshave4SNPsincom-
mon,distinguishingthemfromtheVRS1prototypeandsupport-
ing their origination from a closely related source. Tn1546 of
strainVRS11a/bsharesaSNPwithstrainsVRS2andVRS3a,plac-
ing it between the New York and Pennsylvania elements, and the
Michigan transposons. VRS11a/b possesses an ISE.faecalis1
(ISEf1) insertion in the intergenic region between vanX and vanY
(Fig. 2). VRS11a and VRS11b also possess a common SNP that is
not found in other strains. Finally, even though isolated from a
single patient, a third SNP distinguishes VRS11b from VRS11a,
probably the result of microevolution within the patient.
Comparison of the Tn1546 haplotype network to the single-
copy core gene phylogeny showed that that there was little con-
gruence and that the Tn1546 haplotype network was a poor pre-
dictor of core gene phylogeny (P  0.0001 by the Shimodaira-
Hasegawa test [23]). Phylogenies based upon typing schemes for
the hypervariable repeat regions of clumping factor B (clfB), co-
agulase (coa), and protein A (spa) and based on SCCmec and agr
loci also failed to show a consistent line of VRSA strain descent
(see Table S1A and Fig. S1A, S1B, and S1C in the supplemental
material). The results of each analysis strongly support the model
thateachVRSAisolatearoseastheresultofanindependenttrans-
poson acquisition.
Diversity in plasmid content and Tn1546 location. Tn1546
resides on plasmids in all VRSA strains, not on the chromosome
(even though the chromosome is much larger and would seem to
be a more probable insertion target). Each VRSA strain harbors
plasmids of enterococcal and staphylococcal origin, and in some
cases,cointegratesofthetwo(Fig.3),highlightingtheirhistoryof
cooccurrence in mixed infections with enterococci. Plasmids in-
volved in Tn1546 acquisition vary. Strains VRS1 (24), VRS8,
VRS9, and VRS11a/b possess large portions of the staphylococcal
plasmid pSK41. pSK41 has been shown to enhance gene transfer
from E. faecalis strains harboring pheromone-responsive plasmid
pAD1 because of pheromone cross talk (25) and the pheromone
encoded by a pSK41 gene is detected in the supernatant of strain
VRS1 (15). The transposition of Tn1546 onto pSK41, with con-
comitant loss of the enterococcal donor plasmid, was previously
reported to have occurred in strain VRS1 (24). In strains VRS8
and VRS9, Tn1546 also transposed to pSK41, but at unique sites.
StrainsVRS2,VRS3a,VRS4,VRS5,VRS6,VRS7,andVRS10pos-
sess small fragments with sequence identity to pSK41, but these
identities do not include pSK41 traH, the gene encoding the en-
terococcal plasmid pAD1 pheromone precursor.
FIG 2 Haplotype network of Tn1546 sequences. Numbering of the nucleo-
tide changes refers to the position in sequence in comparison to the prototyp-
ical Tn1546(GenBank accession no. M97297).
FIG 3 Plasmid sequences in VRSA. Heat map showing the extent of occur-
rence of known enterococcal (graded green shades) and staphylococcal plas-
mids (graded yellow to red) (based on detail in Table S5 in the supplemental
material). Plasmids that are deﬁnitely present in the strains are indicated by
squares outlined with a thick black border. The plasmid on which Tn1546
resides is indicated by a white v, and superscript letters a through g denote
unique insertion sites. pLW043* is the pSK41 homolog into which Tn1546
inserted. pWZ909 is the prototype Inc18 enterococcal plasmid involved in
vancomycin resistance transfer. pN315 and pUSA300 were shown in one col-
umn, as these plasmids are nearly identical.
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enterococcal plasmids, which were retained (21, 22). Identical se-
quences surround Tn1546 in both strains, indicating a closely re-
lated source. These megaplasmids likely represent cointegrates of
enterococcal plasmids pS177, p5753cB, and possibly pLG2
(Fig. 3). Mosaic plasmid structures are common in enterococci
(26).Interestingly,theplasmidcontentofstrainVRS7issimilarto
that of strain VRS2, but with Tn1546 remaining on the broad-
host-range Inc18 donor plasmid (Fig. 3). In addition to VRS7,
VRS4 and VRS5 also retain Tn1546 on the Inc18 enterococcal
donor plasmid (17). The sequence of the Inc18 plasmid in VRS10
was completed and found to possess an additional 2.97-kb trans-
poson insertion not present in the others. In VRS4, VRS5, VRS7,
and now VRS10, the location of Tn1546 in the Inc18 donor plas-
mid is identical, highlighting the role of this common element in
theMichiganoutbreak(16).InVRS6,Tn1546wasknowntohave
transposed onto an S. aureus resident plasmid, with loss of the
donor plasmid (16). In this strain, insertion occurred in a novel
plasmid of apparent staphylococcal origin.
StrainsVRS11aandVRS11boriginatedfromasinglepatientin
Delaware, and each strain possesses a cointegrate of enterococcal
and staphylococcal plasmids (see Fig. S2 in the supplemental
material) as conﬁrmed by PCR. The cointegrate is a fusion of
S. aureus plasmid pLUH02 (including genes for beta-lactamase,
enterotoxin,cadmiumresistance,andreplication),andanentero-
coccalpCF10-likeplasmidcarryingpheromone-responsivegenes.
Tn1546residesonthisfusionplasmidinalocationthatisidentical
in both strains (Fig. S2).
No functional lesions identiﬁable in restriction-
modiﬁcationsystemsofmostVRSAstrains.TheSau1restriction
system (27) and a type III-like restriction system (28) represent
knownbarrierstoforeignDNAentry.TheSau1restrictionsystem
consists of an endonuclease, HsdR, encoded by a gene distant
from two pairs of speciﬁcity and modiﬁcation subunits, which
occur on genomic islands Sa and Sa (27). In VRSA, most
Sau1 restriction systems are intact (Fig. 4A). Strain VRS3a pos-
sesses a mutation in the hsdR Sau1 endonuclease gene that results
in a large truncation of the HsdR subunit (see Fig. S2B in the
supplemental material). Several polymorphisms in the Sa
sau1CC5 hsdM1 copy of the HsdM modiﬁcation subunit were
observed(Fig.4A),mostrepresentingminoraminoacidchanges.
However, in the Sa copy of HsdM in strain VRS9, a frameshift
occurs, caused by an adenine duplication at nucleotide position
1213, which truncates the primary translation product (Fig. 4A).
In the Sa sau1CC5 hsdS1 encoded speciﬁcity subunit of
VRS11a/b,anonsensemutationoccursinthesecondcodon,likely
causing a large truncation (Fig. 4A). In contrast to polymorphic
copies in Sa, only one polymorphism was noted in the Sa
copiesofHdsSandHsdMsubunits(Fig.4A).Thatpolymorphism
correspondstoanadditionof3aminoacidstothecarboxytermi-
nus of HsdS in strain VRS2, which seems unlikely to alter func-
tion. Lack of mutations in the Sa genes for HsdM and HsdS, as
well as in most copies of counterparts in the Sa island, indicate
thatSau1islikelyfunctionalinallVRSAstrains,exceptforVRS3a.
AnonsensemutationinthetypeIII-likerestrictionsystemhas
been reported to occur in Japanese CC5 strains (28). The impact
of this speciﬁc mutation on function is unclear, although the type
III-like restriction system clearly poses a barrier to DNA uptake
(28). Only strain VRS10 possesses a polymorphism in this locus
(MQS_01626; a point change that creates a nonsense mutation in
the 12th codon) that is likely to be of functional consequence
(Fig. 4A). Strain VRS9 possesses a polymorphism that leads to a
conservative N89D amino acid substitution. Otherwise, the type
III-like restriction systems of all other VRSA strains appear to be
intact.
Frameshift in dprA in all VRSA strains except VRS3a. One
coding difference related to DNA metabolism that stood out in
comparison of CC5 to non-CC5 genomes was an adenine dupli-
cation at positions 333 and 334 in dprA. This duplication intro-
duces a truncating frameshift (Fig. 4B), potentially eliminating or
alteringDprAfunction.ThischangewasfoundinallNorthAmer-
ican CC5 strains except strain VRS3a. DprA inﬂuences DNA
transformation efﬁciency in Bacillus subtilis (29). In addition to
identifyingpotentialloss-of-functionmutations,suchasthedprA
frameshift, we also searched for other potentially function-
alteringnonsynonymous-codon-changingSNPsuniquetoNorth
American CC5 strains. We identiﬁed 45 SNPs common to all ex-
ceptthemostdivergentstrain,VRS3a(seeTableS2inthesupple-
mental material).
VRSAstrainspossesspolymorphismsintheagrlocus.Simi-
lartorecentobservationsforphage80/81isolatesofS.aureusthat
were prevalent in hospitals in the early 1990s (30), several VRSA
strains (VRS1, VRS2, and VRS8 [see Fig. S1C in the supplemental
material])possesslesionsinakeyglobalregulatorofvirulence,agr
(31). The agr locus is known to attenuate during infection (32),
and this parallels reduced vancomycin susceptibility (33, 34).
CC5 gene content differences include lack of a bacteriocin
operon and presence of genes for diverse superantigens. We
nextexaminedNorthAmericanCC5strains,includingVRSA,for
differences in gene content that could promote coexistence in
polymicrobicinfection(seeTableS3Aand S3Binthesupplemen-
tal material). Most of the variable gene content unique to the
North American CC5 strains occurs within the Sa island (35,
36)(TableS3A;Fig.5).Ofpotentiallyhighimportance,anoperon
(bsa) encoding a lantibiotic bacteriocin (active against other
Gram-positivebacterialspecies[37,38]),isabsentinallmembers
oftheCC5lineage.Instead,thisislandcontainsauniqueclusterof
enterotoxingenes(Fig.5).Interestingly,thispattern—theabsence
of the bacteriocin operon and the presence of nearly identical
complement of superantigens—also occurs in the Sa pathoge-
nicity islands in the EMRSA-15 and MRSA252/EMRSA-16 lin-
eages that are prevalent in hospitals in the United Kingdom (39),
even though the genetic backgrounds are highly dissimilar
(Fig. 5). This suggests active selection for this version of Sa in
the hospital environment. The main difference in Sa islands in
strainsfromtheUnitedStatesandUnitedKingdomisapolymor-
phismthatbreakstheseusuperantigengeneintoent1andent2
pseudogenesintheCC5strains.Incontrasttoaprevioushypoth-
esis (40), our results indicate that the complete seu gene is in the
ancestral state, and a deletion at the base of the CC5 clade created
the pseudogenes. The North American CC5 SA island also in-
cludes leukocidin genes, which encode a toxin that prevents
phagocyticclearance(41,42).CC5strainslackthephagecarrying
the Panton-Valentine leukocidin (PVL) toxin (43) gene. Synteny
analysis independently conﬁrmed each of the above differences
and identiﬁed other changes in gene position of unknown conse-
quence (see Fig. S3 in the supplemental material).
Lipoproteins unique to CC5. S. aureus strains are known to
harbor clusters of lipoprotein genes typically at four locations in
the chromosome—within a Sa element and at three other sites
Kos et al.
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® mbio.asm.org May/June 2012 Volume 3 Issue 3 e00112-12FIG 4 Restriction systems and dprA in VRSA. (A) (1) Alignment of inferred primary translation products of genes encoding the Sau1 restriction nuclease
subunit(HsdR)comparedtotheCC5strainoriginatinginJapan,S.aureusN315.Polymorphismsarehighlighted.Periodsinblocksofsequencedenotestretches
thatareidenticalandnotshown.Numbersabovethesequencesrepresenttheaminoacidpositionintheprototype,fromwhichdistancesrepresentedbydotscan
be discerned. (2) Alignment of inferred primary translation products of genes encoding the modiﬁcation (HsdM) and speciﬁcity (HsdS) subunits in the Sa
island. The locations of restriction-modiﬁcation subunits relative to other key genes are indicated. (3) Alignment of inferred primary translation products of
genes encoding the speciﬁcity (HsdS) subunits in the Sa island. No polymorphisms occur in the Sa HsdM-encoding gene (not shown). (4) Alignment of
inferred primary translation products of genes encoding the type III-like restriction system compared to those of N315 and the CC8 S. aureus NCTC8325
prototype sequence. (B) Alignment of inferred primary translation products of dprA genes of VRSA. VRS3a is the only isolate that encodes a dprA product
identical to that encoded by the Japanese CC5 isolate N315. All other VRSA strains possess a truncating frameshift mutation predicted to generate a premature
termination, and possibly overlapping reinitiation product, as generically designated in the ﬁgure as VRSAa and VRSAb.
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genes than non-CC5 genomes (P  0.05 by the Mann-Whitney
U test; see Fig. S4 in the supplemental material), suggesting that
selection favors their occurrence in these hospital isolates. We
observed strong congruence between lipoprotein- and whole-
genome-based phylogenies, showing that lipoprotein variation
largely parallels chromosome divergence patterns. Interestingly,
BLAST identiﬁed Listeria grayii as the only nonstaphylococcal
species possessing highly related homologs of S. aureus lipopro-
teins (1e24). Gram-positive bacteria process lipoprotein sig-
nal peptides into septa- or octapeptide pheromones (45), which
have been hypothesized to contribute acquisition of vancomycin
resistance by staphylococci (46). Potential pheromone sequences
encoded by the North American CC5 S. aureus genomes were
identiﬁed (Fig. S4).
DISCUSSION
MRSA emerged in the early 1960s and remained largely restricted
tothehospitalenvironment(43).Notuntilresistanceoccurredin
otherlineages30yearslaterdiditrapidlyspreadinthecommunity
(43). CC5 is often the ﬁrst lineage in which new antibiotic resis-
tance genes appear (10, 11, 47). Our work provides quantitative
supportforanearlierproposition,basedlargelyonPFGE(15–17),
that each occurrence of Tn1546-conferred vancomycin resistance
in S. aureus represents an independent acquisition, rather than
patient-to-patient spread. Modeling evolutionary distances on a
time scale (Fig. 6) shows that the last common ancestor of all
VRSA strains occurred at about the time of methicillin introduc-
tion, about 1960, 40 years earlier than vancomycin resistance was
found to have entered the species. The early 1960s also is the ap-
proximate time when the Japanese CC5 isolates diverged. The
modeling analysis employed was based on a calculated mutation
rate of 3.46  106 per site per year and employed conservative,
relaxed-clock assumptions. This rate is in excellent agreement
with the 3.3  106  0.7  106 mutation rate calculated inde-
pendently by others in a rigorous application of second-
generationsequencinginastudyoftheglobalspreadoftheMRSA
lineage ST239 that is prominent in Asia (48). Only in the case of
strains VRS11a and VRS11b, which were isolated from the same
patient, does the uncertainty with respect to the time of strain
divergence extend beyond the date of isolation of that VRSA
strain. The 1960 time point represents the time when the most
divergent VRSA strain, VRS3b (PFGE type USA800), branched
from the rest, most being USA100 PFGE type (Fig. 5). Within the
USA100 group, extensive diversiﬁcation occurred next in about
1978.
Incontrasttoexpectations,VRSArestrictionbarriersappearto
be largely intact. Strain VRS3a possesses a defect in the Sau1 en-
donuclease that is likely to be of functional consequence. How-
ever, most other polymorphisms in the Sau1 system were limited
to the Sa-encoded copy of a modiﬁcation gene, with the Sa-
encoded copy fully intact. Another strain, VRS10, possesses
change in the type III-like restriction, shortening the predicted
primary translation product from 953 amino acids to 856 amino
acids by removal of the amino terminus. The functional conse-
quenceofthistruncationiscurrentlyunknown.Itmaybeimpor-
tant that all VRSA strains, except for the phylogenetic outlier
strain VRS3a, possess a nonsense mutation early in the dprA gene
FIG5 Variation in the SA island of VRSA strains compared to other lineages. The gray shading for the schematic representations of the SA islands shown
to the right of the ﬁgure corresponds to the position within the phylogeny showing the relationship of VRSA genomes to other completely sequenced S. aureus
genomesshowntotheleftoftheﬁgure.Theasteriskinthetopright-handcorneroftheschematicrepresentationinpanelbindicatesthatS.aureusCOLcontains
an IS1811 transposase upstream of bsaA2. The pair of asterisks in the top right-hand corner of the schematic representation in panel d indicate that the far right
endpoint for RF122 is not shown because of phage insertion.
Kos et al.
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(also known as Smf [49]), is highly conserved and contributes to
efﬁcient DNA transformation in naturally competent bacteria
(29, 49–54). Transformation efﬁciency of plasmids in a B. subtilis
dprA mutant is decreased 60-fold (29). Experiments with Esche-
richia coli dprA mutants do not show an obvious role in transfor-
mationorconjugation(55).ItsfunctioninS.aureusremainstobe
explored.
ThemostvariablefeatureoftheVRSAgenomeisplasmidcon-
tent. In all cases, Tn1546 resides on a plasmid, even though it
clearly transposed upon entry into some strains, and because of
size, the chromosome would seem to be the most probable target
for transposon insertion. The basis for the insertion site prefer-
ence for plasmids over the S. aureus chromosome, and also for an
apparentincompatibilitybetweentheenterococcalInc18plasmid
that played a major role in the Michigan outbreak and an endog-
enous S. aureus pSK41 plasmid present in several recipients, is
unknown.VRSAgenomesarerepletewithplasmidsofenterococ-
cal origin, highlighting their cooccurrence in polymicrobic infec-
tions and possibly in other ecologies. The multiplicity of plasmid
structures conveying Tn1546, including S. aureus/enterococcal
cointegrate plasmids, increases the odds of future transfers, pos-
sibly into staphylococcal lineages or species where a lower ﬁtness
cost is incurred.
ThegenomicislandSaisadistinguishingfeatureofCC5.Of
potential ecological importance, the bsa operon usually encoded
within this island is absent in VRSA and other CC5 strains. Fre-
quent application of antibiotics in the hospital environment may
selectforstrainswithanenhancedabilitytocominglewithpoten-
tial resistance donors of other species. Interestingly, this trait is
alsolackinginotherwisehighlydivergentstrainsthatareprevalent
in hospitals in the United Kingdom. The fact that United King-
dom and U.S. hospital strains with widely different chromosomal
backgrounds share very similar Sa islands suggests that there
may be active selection for this conﬁguration in the hospital envi-
ronment. Multidrug-resistant enterococci are much more likely
to lack clustered regularly interspaced short palindromic repeat
(CRISPR) defenses of the genome than commensal strains (56),
indicating that the widespread use of antibiotics has selected for
hospital-adapted bacteria that have enhanced abilities to exist in
mixed communities and exchange resistance determinants. Loss
of bacteriocin production as well as immunity may also explain
why, for 30 years, CC5 MRSA strains were not able to establish
methicillin resistance in the community at a high level. They may
have been inhibited by the functional bacteriocin loci of S. aureus
strains of other sequence types (such as CC8 and CC1) already
present in the community niche. This may also be limiting the
spreadofvancomycinresistancefromCC5strainstootherclades.
Staphylococcal enterotoxins, T cell mitogen superantigens (57)
thatdysregulatethehostresponsebystimulatingCD8regulatoryT
cells (Tregs) at low concentrations (58) and other mechanisms, are
particularlyabundantintheCC5Saelement,aswellasthatofthe
FIG6 ConsensustreeforCC5underrelaxedclockconditions.NorthAmericanCC5strainsareshowninblack,whileotherstrainsareshowningray.Bluebars
indicate range of 95% highest posterior density interval (95% conﬁdence interval, 1.76  106 to 5.22  106). The time of penicillin and methicillin
introduction, as well as the emergence of resistances are shown for reference (PRSA, penicillin-resistant S. aureus). The arrow indicates the estimated time of
divergence of the most distantly related VRSA genome, that of VRS3a (USA800 branch) from the remaining VRSA (mainly USA100) branch of the CC5 clade,
showing that strain divergence occurred far earlier than vancomycin resistance acquisition, supporting the model of independent Tn1546 acquisition.
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togetherwithlipoproteins(59)andleukocidin(41,42)mayfacilitate
overgrowth of mixed populations of bacteria at a site of infection,
contributing to the creation of conditions favorable for resistance
transfer.Notably,mostVRSAstrainsoccurredinmixedinfectionsof
plantarulcersofdiabeticpatients(2),infectionsthatareknowntobe
highly polymicrobic (60, 61).
The hospital is a unique environment, where colonization and
patient-to-patientpropagationofastrainmaydependlessonbac-
terial virulence traits associated with transmission (62) than on
transmission vectors in the form of hospital staff and environ-
mental surfaces and antibiotics (63). Strains that are prevalent in
hospitals are under continuous antibiotic selection pressure and
are exposed to an ever rotating arsenal. CC5 isolates appear to be
very well adapted for surviving and evolving in this environment
by acquiring resistance to new antibiotics.
MATERIALS AND METHODS
Strains. All available VRSA strains were obtained through the Network
ofAntimicrobialResistanceinStaphylococcusaureus(NARSA)(seeTable
S1B in the supplemental material). Since strain VRS3a is believed to be
identical to strain VRS3b, the latter was not sequenced. Strains VRS11b
andVRS11ahadnotbeencharacterized,andbothwereexaminedbecause
of differences in oxacillin resistance. The VRSA strains were routinely
grown on tryptic soy agar containing 10 g/ml vancomycin.
Genome sequencing. For Illumina sequencing, total DNA was puri-
ﬁed from 10-ml overnight cultures using the DNeasy DNA extraction kit
(Qiagen).DNAwastransferredtotheTuftsUniversityDNACoreFacility,
Boston, MA, and a modiﬁed Illumina protocol (64) was used. Libraries
were subjected to multiplexed paired-end sequencing according to the
manufacturer’s speciﬁcations. Sequencing reads were ﬁltered to exclude
reads with a quality score of 25 at any position. The average coverage of
the3-Mbgenomeswas110-fold.Thegenomeswerealsoindependently
sequenced at the University at Buffalo Next-Generation Sequencing and
Expression Analysis Core (Buffalo, NY), by 454 FLX (Roche) to at least
10-fold coverage.
Assemblies. Illumina reads were assembled using Velvet version
1.0.18 (65). The 454 and Illumina reads were then combined and assem-
bled using Newbler 2.3 (Roche). Gene annotations were generated using
theProdigalgenecaller(66).Draftgenomesforstrainsweresubmittedto
GenBank under the following accession numbers: strain VRS1,
AHBK00000000; VRS2, AHBL00000000; VRS3a, AHBM00000000;
VRS4, AHBN00000000; VRS5, AHBO00000000; VRS6, AHBP00000000;
VRS7, AHBQ00000000; VRS8, AHBR00000000; VRS9, AHBS00000000;
VRS10, AHBT00000000; VRS11a, AHBU00000000; and VRS11b,
AHBV00000000.ThecompletegenomesofS.aureusstrainsusedforcom-
parison (see Table S1C in the supplemental material) were downloaded
from GenBank (http://www.ncbi.nlm.nih.gov) and the Sanger website
(http://www.sanger.ac.uk/pathogens).
PCRandtargetedDNAsequencing.Toverifyresultsinsomecasesor
to obtain missing sequence information, PCR was performed using Taq
polymerase (New England Biolabs) with the ampliﬁcation primers listed
in Table S4 in the supplemental material. DNA sequencing of individual
PCR products was performed by the Massachusetts General Hospital
DNA Sequencing Core Facility. Speciﬁc nucleotide sequence alignments
were routinely performed using mafft (67) and ClustalW (68).
Bioinformatic analysis. See Text S1 in the supplemental material.
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